Tampong, Mil Jie S.

HRN: 24-84-14  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2024
CO-AMOXICLAV 625MG (TAB)
04/07/2024
04/14/2024
PO
625 Mg
BID
2nd Degree Rmle And Repair
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: